Financhill
Back

Cellectis SA Vs. Edgewise Therapeutics Industry Stock Comparison

Sell
48

CLLS
Cellectis SA

Last Price:
1.71
Seasonality Move:
-8.86%
Buy
60

EWTX
Edgewise Therapeutics

Last Price:
30.17
Seasonality Move:
30.89%
Sell
48
Cellectis SA (CLLS) is a Sell

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.71. The Score for CLLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CLLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Edgewise Therapeutics (EWTX) is a Buy

Is Edgewise Therapeutics a Buy, Sell or Hold?

  • The current Edgewise Therapeutics [EWTX] share price is $30.17. The Score for EWTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • EWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing selling pressure, which indicates risk of future bearish movement.

EWTX Stock Price Chart

What is Edgewise Therapeutics's stock price today?

  • The Edgewise Therapeutics share price today is $30.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing selling pressure, which indicates risk of future bearish movement.

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 34.96 Sell
Chaikin Money Flow: -41320 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.82 - 2.04) Sell
Bollinger Bands (100): (1.86 - 2.24) Sell

EWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.67 Sell
Relative Strength Index (14 RSI): 46.31 Sell
Chaikin Money Flow: -1448657 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.94 - 33.12) Sell
Bollinger Bands (100): (19.28 - 33.4) Buy

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.86 Sell
20-day SMA: 1.93 Sell
50-day SMA: 1.9 Sell
200-day SMA: 2.28 Sell
8-day EMA: 1.82 Sell
20-day EMA: 1.89 Sell
50-day EMA: 1.94 Sell
200-day EMA: 2.19 Sell

EWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.09 Buy
20-day SMA: 31.24 Sell
50-day SMA: 32.59 Sell
200-day SMA: 22.17 Buy
8-day EMA: 30.32 Sell
20-day EMA: 31.1 Sell
50-day EMA: 30.61 Sell
200-day EMA: 23.35 Buy

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.

Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.30 per share.

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Edgewise Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):